ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physical Medicine Rehabilitation

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 136

$490K Total Retail Price of All Prescriptions

Rank: 4 out of 136

408 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 34%.

Schedule Three
Controlled Substances

26% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 4,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OXYCODONE HCL 717 93 S2 1 2
HYDROCODONE-ACETAMINOPHEN 537 195 S3 2 1
METOPROLOL TARTRATE 210 164 3 28
LEVOTHYROXINE SODIUM 208 125 4 34
OMEPRAZOLE 199 98 5 18
LISINOPRIL 191 130 6 24
SIMVASTATIN 189 124 7 30
FUROSEMIDE 168 113 8 35
ZOLPIDEM TARTRATE 150 48 9 21
PRAVASTATIN SODIUM 149 106 10 77
CARISOPRODOL 143 53 R 11 12
ATORVASTATIN CALCIUM 141 99 12 82
METFORMIN HCL 139 78 13 41
AMLODIPINE BESYLATE 138 108 14 31
TRAMADOL HCL 104 44 15 7
AMITRIPTYLINE HCL 102 50 R 16 29
NEXIUM 99 52 17 68
CARVEDILOL 97 55 18 60
WARFARIN SODIUM 97 85 18 33
GLIPIZIDE 78 63 20 107
CYCLOBENZAPRINE HCL 77 14 R 21 11
CITALOPRAM HBR 75 35 22 27
OPANA ER 70 0 S2 23 19
HYDROCHLOROTHIAZIDE 69 44 24 53
OXYCONTIN 68 42 S2 25 8
ATENOLOL 66 40 26 38
CELEBREX 62 44 27 36
ACTOS 59 48 28 122
PLAVIX 59 38 28 122
CLOPIDOGREL 58 51 30 125
CIPROFLOXACIN HCL 57 29 31 79
CYMBALTA 56 23 32 22
ADVAIR DISKUS 56 37 32 73
GABAPENTIN 56 25 32 3
POTASSIUM CHLORIDE 56 45 32 54
JANUVIA 54 48 36 92
LYRICA 54 34 36 23
AZITHROMYCIN 54 32 36 78
IBUPROFEN 52 17 39 17
SPIRIVA 50 36 40 89
VENTOLIN HFA 50 17 40 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.